Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-24-003836
Filing Date
2024-05-16
Accepted
2024-05-16 18:29:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 5354
  Complete submission text file 0001950047-24-003836.txt   6937
Mailing Address 901 S. MOPAC EXPRESSWAY BARTON OAKS PLAZA ONE, SUITE 250 AUSTIN TX 78746
Business Address
York Charles N II (Reporting) CIK: 0001655962 (see all company filings)

Type: 144

Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005 650 484-0899
Day One Biopharmaceuticals, Inc. (Subject) CIK: 0001845337 (see all company filings)

EIN.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40431 | Film No.: 24957211
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)